Belyakovich Mikhail Vyacheslavovich

Belyakovich Mikhail Vyacheslavovich

Biography

2021-2023

Mikhail Belyakovich began his career KDL in 2011. In this network, he held senior positions - at various times he was a director of one of the company's branches, a director of the retail segment of KDL's medical offices and a commercial director of the chain.

2024: Appointment as CEO of KDL

From January 15, 2024, Mikhail Belyakovich, who had previously worked at the company for more than 10 years, became the new CEO of the KDL laboratory network.

Belyakovich headed KDL instead of Yuri Leonov, who moved to the position of general director of the Invitro group.

According to the press service of the Medskan group (owns the KDL network), Mikhail Belyakovich's experience, his knowledge of the specifics of the KDL laboratory business and professional expertise will help the group in developing diagnostic projects and products and achieving synergy between laboratory and medical business areas. Beljaković himself commented on his appointment as head of KDL as follows:

Of course, this is primarily a big responsibility - both in the KDL perimeter and as part of the Medskan group. Our common goal is to build a leader in the field of non-state health care in Russia, ahead of us there is a lot of work to improve all processes and work efficiency to solve related problems,

According to the general director of the Medskan group, Sergei Ivanchenko, Mikhail Belyakovich knows the KDL business and the team well. With its help, the company will form an effective strategy for further development and integration within the group, Ivanchenko added.

First of all, I want to thank Yuri Leonov for his huge contribution to the development of KDL, largely due to his many years of work, the network became one of the market leaders. Our priority is to preserve the evolutionary development of the network and effective synergy with the medical direction of the Medskan group, - said the head of the Medskan group[1]

Notes